90Y-ITGA6B4

N/A

Report date: 2025/11/11 17:59:33

Base Information

Drug Name90Y-ITGA6B4
Drug Alias NameN/A
ClassificationRadiation-emitting products > Nuclides > Yttrium > 90YRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionAnti-Integrin alpha6/beta4
TargetsIntegrin alpha6/beta4
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPerseus Proteomics IncNational Institute Of Radiological Sciences
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Radiological SciencesPerseus Proteomics Inc
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A